Zephyrnet Logo

Policy Considerations as Children Ages 5-11 Become Eligible for the COVID-19 Vaccine

Date:

A new KFF issue brief lays out key factors for the successful rollout of COVID-19 vaccinations for younger children, ages 5 to 11. This week, the Food and Drug Administration’s (FDA) advisory committee will meet to vote on a request to authorize the Pfizer vaccine for younger children. A final FDA decision, and Centers forMore

PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.

Source: https://www.kff.org/coronavirus-covid-19/press-release/policy-considerations-as-children-ages-5-11-become-eligible-for-the-covid-19-vaccine/

spot_img

Latest Intelligence

spot_img